Bioresorbable Implants Market

According to Stratistics MRC, the Global Bioresorbable Implants Market is accounted for $111.3 billion in 2023 and is expected to reach $206.08 billion by 2030 growing at a CAGR of 9.2% during the forecast period. Bioresorbable implants are medical devices that are made from materials that are eventually broken down and absorbed by the body. The implants' bioresorbable components gradually diffuse in the body, negating the need for a second operation to remove the artificial material. The bioabsorbable implants can be made of both artificial and natural materials. The bioabsorbable implants will reduce the need of second surgery which is required in the case of metallic implants. The bioabsorbable implants are used in many applications such as cardiovascular in the form of stents, screws and pins are used in orthopedics for the treatment of fractures and ankle surgeries, also the implants are used in the form of mesh for the treatment of hernia and Pelvic organ prolapsed.

According to the World Health Organization (WHO) May 2017, factsheet around 17.9 million people died due to cardiovascular disease in 2016, accounting for 31% of all worldwide deaths.



Market Dynamics:

Driver:

Rising demand for bioresorbable bone scaffolds

Bone injuries can be repaired using bioresorbable bone scaffolds. They are progressively absorbed by the body, allowing for the development of new bone tissue. Bone deficiencies brought on by fractures, tumours, or infections can be filled with bioresorbable bone scaffolds. Additionally, the scaffold acts as a support structure for the development of new bone tissue, and it is eventually absorbed by the body. Bone grafts, or fragments of bone that are transplanted from one area of the body to another, can be stabilised using bioresorbable bone scaffolds. The scaffold aids in maintaining the position of the bone graft until it is assimilated into the surrounding bone. Insufficient bone can be treated with bioresorbable bone scaffolds to encourage bone development. Thus, there is an increasing demand for market growth.

Restraint:

Material limitations & cost considerations

In contrast to non-resorbable implants, the selection of materials for bioresorbable implants is currently constrained. Although polymers and ceramics are frequently used, not all applications may be suited to their mechanical characteristics, rates of degradation, or processing methods. Additionally, due to the increased cost of materials, manufacturing procedures, and regulatory restrictions, bioresorbable implants may be more expensive than non-resorbable implants. Healthcare professionals, insurers, and patients all heavily weigh the cost-effectiveness of bioresorbable implants, which can have an impact depending on how they are used. Therefore, these are significant barriers to the market expansion.

Opportunity:

Rising investment in research and development

Bioresorbable implants are the subject of extensive research and development. They can lower the possibility of problems like inflammation and infection. This is due to the fact that they are constructed using substances that are safe for the human body. Additionally, by lowering the need for revision surgery, bioresorbable implants can enhance patient outcomes. This occurs as a result of their progressive body absorption, which enables new tissue to develop in their place. Over time, bioresorbable implants may cost less than conventional implants. New and better bioresorbable implants are being created due to increased funding for research and development. These factors expand the market growth.

Threat:

Lack of awareness and education

Surgeons and other medical specialists, as well as physicians generally, might not be very familiar with or knowledgeable about bioresorbable implants. Lack of knowledge may cause reluctance or limited adoption of this more recent technology. Lack of knowledge may cause people to hesitate before using bioresorbable implants or to be reluctant to change accepted norms. However, in comparison to non-resorbable implants, they can be concerned about the strength, longevity, or long-term functioning of these implants. Healthcare providers may be reluctant to suggest or utilise bioresorbable implants without the necessary training and information, which hinders market growth.

Covid-19 Impact

The COVID-19 pandemic had a profound effect on the world market for bioabsorbable implants. The demand for bioresorbable implants was limited as a result of hospitals deferring elective treatments like orthopaedic surgery because of the epidemic. The COVID-19's limitations on how the chemicals and materials industry operates have hurt the worldwide market. Additionally, due to supply chain disruptions and challenges sourcing raw materials, the market for bioresorbable implants has been severely restricted. The market for bioabsorbable implants is anticipated to expand dramatically over the coming years, despite these short-term challenges.

The ceramics segment is expected to be the largest during the forecast period

The ceramics segment is estimated to hold the largest share. Ceramics are inorganic, non-metallic materials with special qualities that make them ideal for certain uses in bioresorbable implants. Ceramics are widely employed in bioresorbable implants because to their superior mechanical strength, biocompatibility, and osteoconductive qualities. Ceramic materials can act as a scaffold for bone re growth and make it easier for the implant to blend in with the surrounding tissue. Bioresorbable implants made of ceramic are frequently utilised in situations where strong mechanical performance and structural support are necessary.

The biological meshes segment is expected to have the highest CAGR during the forecast period

The biological meshes segment is anticipated to have lucrative growth during the forecast period. Implantable materials called "biological meshes" are created using biological resources like human cadaver donors or animal tissues. Extracellular matrix (ECM), which supports structural integrity and aids in tissue integration, is preserved in these meshes' processing and treatment while cellular components are eliminated. The body usually tolerates biological meshes well because they are made of natural materials. Compared to synthetic materials, they are less susceptible to immunological reactions or rejection. The body has the capacity to restructure and eventually resorb biological meshes. A natural mending process is brought about by the mesh gradually deteriorating and being replaced by fresh tissue.

Region with largest share:

North America commanded the largest market share during the extrapolated period owing to factors such as a high prevalence of cardiovascular disease and an increase in the geriatric population, which is expected to increase the number of cases of osteoporosis and osteoarthritis. Moreover, rise in demand for orthopedic implants and continuous development of advanced technologies to improve the clinical performance of contemporary treatment modalities and devices are projected to fuel the growth of the market in North America during the forecast period.

Region with highest CAGR:

Asia-Pacific is expected to witness profitable growth over the projection period due to extensive awareness about the bioresorbable implants; these areas are most likely to be potential markets for bioresorbable implant in the region. The Asia-Pacific region has a large and growing aging population. This is leading to an increase in the number of people with chronic diseases, such as osteoporosis and osteoarthritis. Bioresorbable implants can be used to treat these diseases and improve the quality of life of patients.



Key players in the market

Some of the key players in the Bioresorbable Implants Market include Medtronic Plc, Dentsply Shiroma., Boston Scientific Corporation, Meryl Life Sciences Pvt. Ltd., Stryker Corporation, Smith & Nephew Plc, KLS Martin, Wright Medical Group, Biotronik Ltd, Syntellix AG, JW Medical Systems LTD, Q3 Medical Devices Limited., Orbusneich Medical., Depuy Synthes, Bioretec Ltd, Conmed Corporation and Zimmer Biomet Holdings, Inc.

Key Developments:

In September 2022, Biotronik Ltd Announces Collaboration with AliveCor As First In A Series of Strategic Partnerships to Disrupt Cardiac Digital Health With AI-Enabled Solutions. This partnership aims to enable faster diagnosis, more informed clinical decision-making and effective treatment by bringing complete information to every step in the diagnosis, device implant, and management process.

In February 2021, Stryker Corporation and Brainomix announced a new partnership that will represent a transformative solution for stroke networks across EMEA, enabling broader utilization of stroke imaging AI tools to help more patients gain access to life-saving treatments.

Product Types Covered:
• Stents
• Biological Meshes
• Fixation Devices
• Resorbable Mesh
• Resorbable Band
• Resorbable Scaffolds
• Resorbable Tethers

Material Types Covered:
• Ceramics
• Metallic
• Polymers
• Other Material Types

Applications Covered:
• Orthopedics
• Cardiovascular
• General Surgery
• Cosmetic Surgery
• Cranial
• Dental Surgery
• Vascular Surgery

End Users Covered:
• Specialty Clinics
• Hospitals
• Ambulatory Surgical Centers
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances